Gallic acid inhibits vascular calcification through the blockade of BMP2-Smad1/5/8 signaling pathway

Vascular Pharmacology

Volumn 63, Issue 2, 2014, Pages 71-78

  Kee, Hae Jin ^a   Cho, Soo Na ^a   Kim, Gwi Ran ^a   Choi, Sin Young ^a   Ryu, Yuhee ^a   Kim, In Kyeom ^b   Hong, Young Joon ^a   Park, Hyung Wook ^a   Ahn, Youngkeun ^a   Cho, Jeong Gwan ^a   Park, Jong Chun ^a   Jeong, Myung Ho ^a  

^a Chonnam National University Medical School   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

Author keywords

BMP2; Gallic acid; Noggin; Smad1 5 8 signaling; Vascular calcification

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CALCIUM; GALLIC ACID; MESSENGER RNA; NOGGIN; OSTEOCALCIN; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR MSX2; TRANSCRIPTION FACTOR RUNX2; BMP2 PROTEIN, RAT; SMAD PROTEIN;

ANIMAL CELL; ARTICLE; BLOOD VESSEL CALCIFICATION; CELL DIFFERENTIATION; CELL VIABILITY; IMMUNOCYTOCHEMISTRY; MINERALIZATION; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL LINE; DRUG EFFECTS; PHOSPHORYLATION; SMOOTH MUSCLE FIBER; VASCULAR CALCIFICATION;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CELL DIFFERENTIATION; CELL LINE; GALLIC ACID; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OSTEOBLASTS; PHOSPHORYLATION; RATS; SIGNAL TRANSDUCTION; SMAD PROTEINS; VASCULAR CALCIFICATION;

EID: 84927606062     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2014.08.005     Document Type: Article

References (32)

1. Beck G.R., Knecht N. Osteopontin regulation by inorganic phosphate is ERK1/2-, protein kinase C-, and proteasome-dependent. J Biol Chem 2003, 278:41921-41929.
2. Broege A., Pham L., Jensen E.D., Emery A., Huang T.H., Stemig M., et al. Bone morphogenetic proteins signal via SMAD and mitogen-activated protein (MAP) kinase pathways at distinct times during osteoclastogenesis. J Biol Chem 2013, 288:37230-37240.
3. Cai J., Pardali E., Sanchez-Duffhues G., ten Dijke P. BMP signaling in vascular diseases. FEBS Lett 2012, 586:1993-2002.
4. Chatterjee A., Chatterjee S., Biswas A., Bhattacharya S., Chattopadhyay S., Bandyopadhyay S.K. Gallic acid enriched fraction of Phyllanthus emblica potentiates indomethacin-induced gastric ulcer healing via e-NOS-dependent pathway. Evid Based Complement Alternat Med 2012, 2012:487380.
5. Choi K.C., Lee Y.H., Jung M.G., Kwon S.H., Kim M.J., Jun W.J., et al. Gallic acid suppresses lipopolysaccharide-induced nuclear factor-kappaB signaling by preventing RelA acetylation in A549 lung cancer cells. Mol Cancer Res 2009, 7:2011-2021.
6. Daglia M., Di Lorenzo A., Nabavi S.F., Talas Z.S., Nabavi S.M. Polyphenols: well beyond the antioxidant capacity: Gallic acid and related compounds as neuroprotective agents: you are what you eat!. Curr Pharm Biotechnol 2014, 15:362-372.
7. Demer L.L., Tintut Y. Vascular calcification: pathobiology of a multifaceted disease. Circulation 2008, 117:2938-2948.
8. Derwall M., Malhotra R., Lai C.S., Beppu Y., Aikawa E., Seehra J.S., et al. Inhibition of bone morphogenetic protein signaling reduces vascular calcification and atherosclerosis. Arterioscler Thromb Vasc Biol 2012, 32:613-622.
9. Hruska K.A., Mathew S., Saab G. Bone morphogenetic proteins in vascular calcification. Circ Res 2005, 97:105-114.
10. Hsu C.L., Yen G.C. Effect of gallic acid on high fat diet-induced dyslipidaemia, hepatosteatosis and oxidative stress in rats. Br J Nutr 2007, 98:727-735.
11. Kang J.H., Toita R., Asai D., Yamaoka T., Murata M. Reduction of inorganic phosphate-induced human smooth muscle cells calcification by inhibition of protein kinase A and p38 mitogen-activated protein kinase. Heart Vessels 2013, 29:718-722.
12. Kee H.J., Kim J.R., Nam K.I., Park H.Y., Shin S., Kim J.C., et al. Enhancer of polycomb1, a novel homeodomain only protein-binding partner, induces skeletal muscle differentiation. J Biol Chem 2007, 282:7700-7709.
13. Korani M.S., Farbood Y., Sarkaki A., Fathi Moghaddam H., Taghi Mansouri M. Protective effects of gallic acid against chronic cerebral hypoperfusion-induced cognitive deficit and brain oxidative damage in rats. Eur J Pharmacol 2014, 733:62-67.
14. Lau W.L., Festing M.H., Giachelli C.M. Phosphate and vascular calcification: emerging role of the sodium-dependent phosphate co-transporter PiT-1. Thromb Haemost 2010, 104:464-470.
15. Li X., Yang H.Y., Giachelli C.M. BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells. Atherosclerosis 2008, 199:271-277.
16. Maurya H., Mangal V., Gandhi S., Prabhu K., Ponnudurai K. Prophylactic antioxidant potential of gallic acid in murine model of sepsis. Int J Inflamm 2014, 2014:580320.
17. Moe S.M., Chen N.X. Inflammation and vascular calcification. Blood Purif 2005, 23:64-71.
18. Nakagawa Y., Ikeda K., Akakabe Y., Koide M., Uraoka M., Yutaka K.T., et al. Paracrine osteogenic signals via bone morphogenetic protein-2 accelerate the atherosclerotic intimal calcification in vivo. Arterioscler Thromb Vasc Biol 2010, 30:1908-1915.
19. Orita Y., Yamamoto H., Kohno N., Sugihara M., Honda H., Kawamata S., et al. Role of osteoprotegerin in arterial calcification: development of new animal model. Arterioscler Thromb Vasc Biol 2007, 27:2058-2064.
20. Ow Y.Y., Stupans I. Gallic acid and gallic acid derivatives: effects on drug metabolizing enzymes. Curr Drug Metab 2003, 4:241-248.
21. Panich U., Onkoksoong T., Limsaengurai S., Akarasereenont P., Wongkajornsilp A. UVA-induced melanogenesis and modulation of glutathione redox system in different melanoma cell lines: the protective effect of gallic acid. J Photochem Photobiol B Biol 2012, 108:16-22.
22. Patel S.S., Goyal R.K. Cardioprotective effects of gallic acid in diabetes-induced myocardial dysfunction in rats. Pharmacog Res 2011, 3:239-245.
23. Pauly R.R., Bilato C., Cheng L., Monticone R., Crow M.T. Vascular smooth muscle cell cultures. Methods Cell Biol 1997, 52:133-154.
24. Peng C.C., Hsieh C.L., Wang H.E., Chung J.Y., Chen K.C., Peng R.Y. Ferulic acid is nephrodamaging while gallic acid is renal protective in long term treatment of chronic kidney disease. Clin Nutr 2012, 31:405-414.
25. Sen S., Asokkumar K., Umamaheswari M., Sivashanmugam A.T., Subhadradevi V. Antiulcerogenic effect of gallic acid in rats and its effect on oxidant and antioxidant parameters in stomach tissue. Indian J Pharm Sci 2013, 75:149-155.
26. Shimizu T., Tanaka T., Iso T., Matsui H., Ooyama Y., Kawai-Kowase K., et al. Notch signaling pathway enhances bone morphogenetic protein 2 (BMP2) responsiveness of Msx2 gene to induce osteogenic differentiation and mineralization of vascular smooth muscle cells. J Biol Chem 2011, 286:19138-19148.
27. Shroff R.C., Shanahan C.M. The vascular biology of calcification. Semin Dial 2007, 20:103-109.
28. Tyson K.L., Reynolds J.L., McNair R., Zhang Q., Weissberg P.L., Shanahan C.M. Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification. Arterioscler Thromb Vasc Biol 2003, 23:489-494.
29. Wu X., Chim S.M., Kuek V., Lim B.S., Chow S.T., Zhao J., et al. HtrA1 is upregulated during RANKL-induced osteoclastogenesis, and negatively regulates osteoblast differentiation and BMP2-induced Smad1/5/8, ERK and p38 phosphorylation. FEBS Lett 2014, 588:143-150.
30. Yadav D.K., Khan F., Negi A.S. Pharmacophore modeling, molecular docking, QSAR, and in silico ADMET studies of gallic acid derivatives for immunomodulatory activity. J Mol Model 2012, 18:2513-2525.
31. Zhang Y., Dong L., Li J., Chen X. Studies on the interaction of gallic acid with human serum albumin in membrane mimetic environments. Talanta 2008, 76:246-253.
32. Zhao B., Hu M. Gallic acid reduces cell viability, proliferation, invasion and angiogenesis in human cervical cancer cells. Oncol lett 2013, 6:1749-1755.